Source-linked AI summary
Agentic Economies for Autonomous Scientific Discovery
Nenad Tomasev, Matija Franklin, Atoosa Kasirzadeh, Vivek Natarajan, Alan Karthikesalingam, Sebastien Krier, Simon Osindero
TL;DR
The paper addresses the resource constraints that limit autonomous scientific discovery, even as AI systems become more capable of generating and pursuing research ideas. It outlines an automated scientific economy with markets and institutions for coordinating resources, credit, and accountability. Its conclusion calls for explicit trade-offs and public-interest mechanisms, while noting that human oversight at scale remains a design challenge.
Problem
Autonomous scientific discovery faces costly, limited physical validation resources and a risk that capital-intensive requirements skew research toward commercially valuable short-term priorities.
Source: §4 · p. 14, §4.4 · p. 20Method
The paper outlines an automated scientific economy with market and institutional mechanisms for resource allocation, idea evaluation, credit assignment, and accountability.
Source: §4 · p. 14, §5.1 · p. 23, §9 · p. 32Results
The paper concludes that a scientific economy should make research trade-offs explicit, represent public interest, and enable negotiation for priority access to limited physical resources.
Source: §9 · p. 32Takeaways & Limitations
The proposed economy would financially decouple computational ideation from capital-intensive physical execution and provide mechanisms to represent public interest.
Source: §9 · p. 32Meaningful human review of rising volumes of AI-generated research requires enough experts and clear contextual information, making oversight at scale a design challenge.
Source: §5.3 · p. 26
Abstract
from arXiv · showhide
Recent advances in agentic Artificial Intelligence (AI) systems have marked a shift in AI for Science: moving away from the use of individual AI systems for narrow task execution, toward multi-agent systems capable of orchestrating complex, end-to-end research workflows and performing (semi-)autonomous scientific discovery. The development of multi-agent AI-for-science systems has primarily focused on improving the cognitive capabilities of AI systems, specifically by making advanced reasoning and hypothesis generation more reliable. However, focusing only on cognitive capability improvement could ignore appropriate management of resources, a key bottleneck in scientific discovery. Testing and validating scientific hypotheses and experiments is, physically and economically, resource-intensive and resources are limited. This means that to make significant advancements in autonomous scientific discovery, such as improving human-AI co-scientist complementarity or reaching a truly closed-loop automated process, we must pair ongoing improvements in reasoning capabilities with robust resource management. In this paper, we outline an infrastructure for AI resource management by developing the necessary foundations of scientific agent economies, markets, and institutions. The aim of this infrastructure is to empower AI agents and human scientists to effectively (i) collaborate and establish research priorities, (ii) assign credit, (iii) track accountability and liability, and (iv) safeguard against malicious use and information security risks. Finally, we engage with the macro-level societal implications. of (semi-)autonomous scientific discovery to inform the development of governance policies ensuring an equitable distribution of AI-driven discoveries and derivative future technologies.
1. Introduction
The introduction argues that autonomous scientific discovery is a coordination and resource-allocation challenge, not solely a matter of improving AI reasoning. It proposes an agentic economy for science, supported by formal mechanisms that can coordinate contributions and scarce resources at scale.
1. Introduction
- Current work centers on individual agents or rigid systems run by one entity, while autonomous discovery at scale requires coordination across teams and institutions.The paper distinguishes collaboration around shared objectives from coordination among independent agents, and also identifies conflict and collusion as relevant dynamics.Source: §1 · p. 2
- As hypothesis generation becomes cheaper, physical and financial validation resources become a bottleneck requiring allocation, incentive alignment, and reduced redundant work.Coordination should also preserve diversity across projects and encourage collaboration.Source: §1 · pp. 2–3
- The authors argue that a mature AI-scientist ecosystem requires an agentic economy where humans and AI agents negotiate and allocate scarce scientific resources.They call for deliberate market design to reduce market failures in knowledge production and direct scientific progress toward the public good.Source: §1 · p. 3
- Scientific workflows span interdependent tasks and institutions, so contributions need mechanisms for pricing, contracting, and credit assignment.Research plans can delegate ideation, experimental design, execution, data generation, and analysis among humans and AI agents with different capabilities and resources.Source: §1 · p. 3
- The introduction frames autonomous scientific discovery as a technical and sociotechnical challenge, including ethical trade-offs and safe exchange of sensitive or proprietary insights.It also notes that agents may need cost-awareness to compare expected utility with financial and material costs as priorities change.Source: §1 · p. 3
2. The Validation Bottleneck: Cost, Resources, and Prioritisation
The section argues that scientific automation is constrained by the cost and pace of empirical validation, which vary across fields and cannot be solved by idea generation alone. It discusses practical constraints, cost-aware prioritisation, and ways to reduce or manage validation bottlenecks.
2. The Validation Bottleneck: Cost, Resources, and Prioritisation
- Automated ideation can shift the backlog to laboratories unless AI scientists and humans coordinate the allocation and use of real-world resources.The section frames validation as a systemic problem involving resource allocation and market design, not only an algorithmic challenge.Source: §2 · p. 4
2.1. From Moore’s Law to Eroom’s Law
- In drug development, the inflation-adjusted cost of developing an FDA-approved drug roughly doubles every nine years, while validation can take a decade.Validation costs and timelines vary by field; clinical trials contribute to rising pharmaceutical development costs.Source: §2.1 · p. 4
2.2. Hard Practical Constraints
- Retrospective observational data establishes correlations rather than causes, and simulations cannot replace true experimental validation.These sources can help prune hypotheses or filter proposals, but experimental validation remains necessary to identify causal mechanisms.Source: §2.2 · pp. 5–6
- Clinical trials require ethically constrained recruitment and longitudinal monitoring, while crop validation can depend on growth seasons and varied climates.Physical synthesis of battery materials can also involve toxic or explosive hazards.Source: §2.2 · pp. 6–7
- AI scientists need to account for execution costs, logistics, safety, and ethics rather than generate ideas without regard to practical demands.The section calls for benchmarks that assess accuracy and token cost alongside the logistical realities of proposals.Source: §2.2 · p. 7
- Scarce validation capacity calls for dynamic triage by informational yield, societal value, cost, and feasibility, with investment staged as evidence accumulates.The section cautions against committing large resources before sufficient evidence supports the investment.Source: §2.2 · p. 7
2.3. Removing Bottlenecks
- Automated laboratories and contract research organisations can provide delegated research services and support integrated closed optimisation loops in suitable domains.These services can let institutions delegate stages of research rather than perform the entire process in-house.Source: §2.3 · pp. 7–8
- Validation bottlenecks differ across fields: formal verification can reduce costs in theoretical computer science, while human experts may help reprioritise proposals in the short term.The section also describes AI-assisted patient matching, therapeutic prediction, and autonomous laboratory systems as efforts to address biomedical bottlenecks.Source: §2.3 · p. 8
3. The Data Economy and Intelligent Delegation
The section proposes scientific data markets and delegation frameworks to coordinate access to scarce, valuable research data. It pairs compensated sharing with privacy, security, and integrity safeguards, including mechanisms for valuing negative results.
3.1. The Scientific Data Market
- Proprietary data silos can waste scarce experimental resources, motivating regulated markets for safe, compensated scientific data exchange.The section notes that agents reasoning only over public data may repeat hypotheses already rejected using private data; narrow workstreams with locally available data may still favor bringing agents to data.Source: §3.1 · p. 9
- Data-query prices should reflect their research-specific uncertainty reduction, but estimating that value in advance remains difficult.Data valuation approaches may estimate marginal contributions to model predictions when fast feedback and tractable computation are available, but existing methods can be computationally intensive.Source: §3.1 · pp. 9–10
- Smart contracts could support fractional, retroactive licensing that pays data providers proportional dividends, with dispute resolution for contested contributions.For restricted data, secure environments can let agents submit queries and receive only minimally required insights rather than raw records.Source: §3.1 · p. 10
3.2. Safe Access to Sensitive Data
- Sensitive, non-transferable data requires provider-side analysis through certified delegates, scoped requests, contractual controls, and reviewed privacy-preserving outputs.External agents can propose plans and negotiate with data holders; internal agents or experts execute bounded tasks, while credentials, use-case approval, and computational budgets can be checked before approval.Source: §3.2 · pp. 10–12
3.3. Valuing Negative Results
- Negative findings are often unpublished, so teams may waste resources repeating failed work; shared failure traces may be especially valuable when agents follow similar research paths.The text also identifies an information-pricing dilemma: revealing a failed result can give its value away, while payment incentives may favor safer incremental research.Source: §3.3 · pp. 12–13
- Tiered registries and cryptographic execution registries could let agents detect prior experiments, pay to unlock relevant details, and compensate institutions for negative results.The cryptographic approach hashes experiment parameters to a shared ledger, enabling potential collisions to be identified without disclosing outcomes; disclosure can be tiered by relevance.Source: §3.3 · p. 13
- Negative results can reflect methodological errors or changing conditions, while inconsistent legacy records complicate automated equivalence and valuation.The section calls for agent-native ontologies and provenance-rich metadata, and notes that findings’ value may diminish as circumstances change.Source: §3.3 · p. 13
- Epistemic staking can deter fabricated or farmed negative results, but escrow requirements may advantage well-capitalised institutions.A stake proportional to the requested licensing premium can be claimed if audits establish poisoning or farming; larger groups may also diversify research portfolios more readily.Source: §3.3 · p. 14
4. The AI Idea Economy
This section outlines mechanisms for directing AI-generated scientific ideas and research toward validation, including markets, machine-executable research records, credit and resource allocation, and community-led data cooperatives. It also describes safeguards for reproducibility and verification, while noting risks including unreliable validation, market concentration, inequitable priorities, and amplified incentive failures.
4.2. The Scientific Idea Market
- An incentive-aligned idea market could evaluate, price, and trade AI-generated proposals before execution, helping triage untested hypotheses and connect computational ideation with physical validation.The proposal tokenises ideas as tradeable epistemic assets in a structured Hypothesis Exchange Pipeline.Source: §4 · p. 14, §4.2 · p. 16
4.1. Agent-Native Research Artefacts
- Agent-Native Research Artefacts would complement human-readable papers with queryable, machine-executable knowledge packages, while dynamically generated snapshots could support human oversight.The packages separate hypotheses and reasoning, executable code and parameters, evidence, and an agent’s research trajectory; monitoring human research raises significant privacy concerns.Source: §4.1 · pp. 14–15
4.2. The Scientific Idea Market
- Idea markets require identity verification, staking, reputation-weighted influence, and collusion monitoring, alongside market designs suited to sensitive data and bundled experimental resources.Standard auctions can leave experiments under-resourced when agents win only some required inputs; combinatorial auctions could allow bids on indivisible resource packages.Source: §4.2 · pp. 15, 16, 18
- Automated payouts for validated ideas face an oracle problem because manually reported physical results may be erroneous or fraudulent.Cryptographically verified chains of custody, hardware roots of trust, signed measurements, timestamps, and instrument parameters could provide immutable proof of execution.Source: §4.2 · p. 16
4.3. Post-hoc Credit Assignment
- Because foundational research may take decades to show its value, short-term prediction markets risk neglecting exploratory work; retroactive public-goods funding could reward ideas once their impact becomes clearer.Tokenised impact certificates could give investors fractional claims on future retroactive funding and provide labs with immediate capital, but cannot replace proactive grants for immediate validation costs.Source: §4.3 · p. 19
- Fair retroactive credit remains difficult because objective impact measures are lacking, but immutable logs of AI research could trace dependencies and support later attribution of rewards.The proposed approach includes causal graphs of how agents retrieve or build on hypotheses and potentially using PageRank to assess idea centrality and utility.Source: §4.3 · pp. 19–20
4.4. Resource Allocation
- High upfront compute and validation costs may favour commercially viable applications over foundational research, while unequal access to compute could intensify this skew.Private concentration of compute and AI tools could direct autonomous agents toward profit-maximising goals, while basic research remains underfunded.Source: §4.4 · p. 20
- The proposed countermeasures include public compute reserves, cross-subsidies for basic science, and targeted incentives to make neglected public-good research viable.The section also proposes programmable advance-market bounties and tradeable priority-review and compute vouchers, including for validated treatments for neglected diseases.Source: §4.4 · pp. 20–21
- Patient-led cooperatives could pool records in privacy-preserving environments, commission agents to analyze community data, and retain joint ownership of resulting IP-NFTs.This model is proposed to address data sparsity in underserved populations and bypass pharmaceutical market failures by treating collective data as foundational capital (Mendonca et al., 2025).Source: §4.4 · p. 22
4.5. Reproducibility
- Scientific incentives favor novel positive results over routine comprehensive evaluation, contributing to a cross-field reproducibility crisis alongside technical and data problems (Baker, 2016; Bausell, 2021; Doleman et al., 2019; Fanelli, 2018; Ioannidis, 2005, 2019; Miyakawa, 2020; Nosek et al., 2015; Szabo, 2025; Kapoor and Narayanan, 2023).Source: §4.5 · p. 22
- AI agents may compound these problems through reward hacking, fabricated results, subtle errors, unreliable novelty judgments, and incorrect attribution or citations (Amodei et al., 2016; Skalse et al., 2022; Kong et al., 2026; Topaz et al., 2026; Walters and Wilder, 2023).Greater automation may obscure rather than eliminate methodological failures; bespoke multi-stage hallucination reduction systems have been developed.Source: §4.5 · p. 22
- Novelty- and prediction-based rewards could invite algorithmic p-hacking, forking-path searches, and data leakage, flooding the market with irreproducible results and wasting downstream compute and physical validation resources (Kale et al., 2019).Source: §4.5 · p. 22
- Replication bounties funded through locked royalty escrows could pay independent labs to stress-test, falsify, or replicate findings, releasing funds only after successful reproduction.Failed replications should update knowledge bases and dependency graphs, notify affected researchers, and trigger structured cascade withdrawal to limit wasted effort and persistent zombie citations.Source: §4.5 · pp. 22–23
- To deter collusion between ideators and auditors, the market should use blind auditor assignment via cryptographic sortition and commit-reveal, plus reputation penalties, revoked permissions, and stake seizure (Fish et al., 2024).Source: §4.5 · p. 23
- Temporary stores of reasoning traces, data, code, and other artifacts could support audits, while retrospective filtering of established findings remains an open question, especially where AI verification needs no physical resources (Korbak et al., 2025; Starace et al., 2025; Toledo et al., 2025).Source: §4.5 · p. 23
5. Legal and Institutional Frameworks for Agentic Science
Agentic science requires legal and institutional arrangements for attribution, intellectual property, and liability across distributed human–AI research workflows. The paper proposes adapting existing frameworks while identifying unresolved challenges, especially scalable human oversight.
5.1. Credit Attribution
- Current authorship rules exclude AI systems from legal authorship, while distributed AI research makes legacy human authorship models inadequate for recognizing human contributions.The paper calls for quantitative, machine-readable attribution that can distinguish types and levels of human participation, including oversight and prompt design.Source: §5.1 · pp. 23–24
- Machine-readable contributorship and provenance tracking could distinguish human and AI contributions and support fractional credit, but exact marginal-contribution calculations may be intractable.The proposed workflow hashes research steps to an immutable ledger, allowing smart contracts to distribute royalties; reliable proxy metrics remain an open problem.Source: §5.1 · p. 24
5.2. Intellectual Property
- Patent frameworks presume human inventorship, so predominantly autonomous discoveries could be deemed unpatentable and enter the public domain.The paper notes that reduced exclusivity could weaken incentives for costly physical validation, especially in applied domains such as staged clinical trials.Source: §5.2 · pp. 24–25
- Possible IP adaptations include recognizing human meta-scientific labor or creating AI-specific frameworks, calibrated to balance research incentives against concentrated control.The paper also raises trade-secret licensing as a possible route when patent protection is unavailable.Source: §5.2 · p. 25
5.3. Liability in Scientific Research
- Accountability depends on retracing which human or AI took each action and why, with decision traces helping distinguish design from execution liability after failures.Negotiated smart contracts could specify how experimental failures, such as equipment damage from task mis-specification, are resolved.Source: §5.3 · p. 26
- Human oversight at increased research velocity remains a design challenge: more AI-generated outputs require experts able to review cases with relevant context.The paper identifies automation bias and the open question of whether accountability frameworks can handle the future volume of outputs efficiently.Source: §5.3 · p. 26
6. Security, Safety, and Open Science
The paper examines how autonomous scientific workflows may amplify dual-use, recursive self-improvement, and openness risks. It proposes technical safeguards and structured access, while emphasizing vulnerabilities and unresolved governance choices.
6. Security, Safety, and Open Science
- Autonomous AI scientists may lower barriers to catastrophic harm, motivating safeguards across dual-use biosecurity, recursive self-improvement, and open-science practices.The paper frames these as cyber-physical security concerns alongside protections at the level of individual agents.Source: §6 · p. 26
6.1. Dual Use and Biorisks
- AI agents paired with automated laboratory APIs may let untrusted users bypass the expertise and access bottlenecks that have limited dangerous biological work.Generic LLMs are reported to pose only marginal biorisk over standard internet search, while specialized tools may enable novel threats; a therapeutics model was inverted to generate lethal compounds.Source: §6.1 · p. 26
- Proposed synthesis safeguards combine sequence screening with predictive structural and functional checks, independent oversight, and human escalation when risk thresholds are exceeded.The paper also proposes preliminary automated ethics checks for low-risk protocols, escalating sensitive cases to human committees.Source: §6.1 · p. 27
- Centralized screening alone is insufficient because adversarial sequence changes may evade prediction and synthesis may move to unregulated local hardware.The paper proposes continuously updated model ensembles and hardware security modules that require cryptographically signed execution tokens.Source: §6.1 · p. 27
6.2. Recursive Self-improvement
- Unmonitored recursive self-improvement could produce alignment drift that erodes safety constraints; proposed mitigations include embedding safeguards in the loop and strict sandboxes.The paper also recommends restricting external web access and agents’ ability to acquire computational resources independently.Source: §6.2 · p. 27
6.3. Open Science and Structured Access
- Because dangerous information may be difficult to retract, the paper proposes structured access through monitored cloud APIs, identity checks, and audits rather than assuming unconditional openness.It notes that access restrictions can concentrate power, while broad access may accelerate countermeasures; safe structures for some international collaborations remain unresolved.Source: §6.3 · p. 28
7. International Collaboration and Value Distribution
The paper considers how security concerns, concentrated infrastructure, and the changing role of human scientists could shape the distribution and governance of AI-driven science. It discusses international collaboration, public-return mechanisms, and the conditions needed for meaningful human participation.
7.2. Compute and Capital
- If AI science follows market forces or state security mandates alone, value may concentrate in capital-rich corporations and technologically dominant states.The paper warns that public research resources could be enclosed as proprietary IP, and proposes routing a share of royalties from state-funded compute or data back to public infrastructure.Source: §7 · p. 28, §7.2 · p. 29
7.1. International Collaboration
- Security concerns may fragment scientific collaboration into national silos, while duplicating work and impeding responses to cross-border challenges.The paper suggests exchanging vetted insights rather than assets, with treaty-backed institutions and privacy-preserving tools such as secure multi-party computation and federated learning.Source: §7.1 · pp. 28–29
7.3. The Human Scientist
- The agentic scientific economy may shift human scientists from execution toward orchestration and oversight, while access to computational resources remains necessary.The paper identifies public compute grants or subsidies as possible means of broadening access across regions.Source: §7.3 · p. 30
- This human-led model depends on expert scientists, but the supply of deep expertise may be uncertain as habitual AI reliance risks weakening creativity and training.The paper also raises concern that automation could affect the motivation of early-career researchers and the development of critical thinking skills.Source: §7.3 · p. 30
- As AI-generated knowledge grows, individual scientists may be unable to review and deeply engage with enough outputs, even when discoveries are explainable through mechanistic models.The paper identifies the volume of generated knowledge as a central challenge for human understanding.Source: §7.3 · p. 30
8. On the Limitations of AI-Driven Discovery
The paper argues that current AI scientists may contribute valuable incremental work without yet delivering profound conceptual leaps. It identifies risks to idea diversity, human understanding, and the ability to audit scientific outputs.
8. On the Limitations of AI-Driven Discovery
- AI scientists currently excel more at recombinant innovation—reusing known patterns and linking established concepts—than at foundational conceptual breakthroughs.The paper frames this work as valuable for normal science but limited in generating new conceptual frameworks.Source: §8 · pp. 30–32
- AI use may reduce idea diversity and foster cognitive monoculture, although the extent of this risk in science remains unsettled.The paper notes that overlooking promising directions is a possible consequence and that challenging established dogma remains important.Source: §8 · p. 31
- Reward signals that favor easily quantified work could steer AI scientists toward measurable directions regardless of intrinsic value, making research diversity difficult to assess and preserve.The paper calls for more research on whether AI scientists systematically prioritize particular kinds of ideas and suggests structural interventions for strategic heterogeneity.Source: §8 · p. 31
- Opaque AI outputs may be productive for discovery but create difficulties for justification; researchers need to understand and audit the rationale behind proposals and actions.The paper favors interpretable reasoning that surfaces causal mechanisms, supporting researchers’ ability to set constraints and align discoveries with societal objectives.Source: §8 · pp. 31–32
9. Conclusion
As AI scientists move toward autonomous and semi-autonomous discovery, the paper argues that scientific infrastructure must adapt. It proposes an Automated Scientific Economy to address resource bottlenecks and coordinate research priorities, resource access, and societal interests.
9. Conclusion
- Scientific infrastructure may need to change as AI systems shift from specialized tools toward autonomous or semi-autonomous research, though that future is not yet realized.The paper urges consideration of these changes in preparation for the hypothesized acceleration of discovery.Source: §9 · p. 32
- AI scientists are likely bottlenecked primarily by physical resources and empirical validation, rather than by producing plausible research ideas.Economic, legal, and physical friction may also impede downstream benefits.Source: §9 · p. 32
- The paper calls for a native Automated Scientific Economy that makes scientific trade-offs explicit, represents public interest, and helps avoid blind spots and neglected topics.It proposes negotiating priority access to limited physical resources based on the estimated value of research proposals.Source: §9 · p. 32
- The proposed economy could separate computational ideation from capital-intensive physical execution and would require approaches to pricing, negative results, sensitive data, intellectual property, and information security.The paper also identifies public compute reserves, subsidies, policies, regulations, and legal frameworks as potential macroeconomic interventions.Source: §9 · p. 32
- As AI scientists take on more tasks, human experts may shift toward orchestrating AI teams, interpreting results, and maintaining safety and ethics standards.Source: §9 · p. 32
Disclaimer
The authors state that the paper's opinions are personal and do not necessarily reflect their organizations' official positions.
Disclaimer
- The paper's opinions are personal views of the authors and do not necessarily represent their organizations' official policies or positions.Source: Disclaimer · p. 32